RSS Feeds | Pharmaceutical News Feed http://www.news-medical.net/Pharmaceutical news.asp
Latest Pharmaceutical News From News-Medical.Net Total news: 10 Last news: August 31, 2007 03:00:00
|
| FDA To Study How People React To Direct-to-Consumer Drug Ads August 24, 2007 19:00:00FDA on Tuesday announced plans to study whether positive images featured in direct-to-consumer television advertisements for medications "distract consumers from carefully considering and encoding" audio warnings about the treatments, the AP/Seattle Post-Intelligencer reports. [click link for full article] - [Read more] |
| NCPA Statement On Chamber Of Commerces Endorsement Of Community Pharmacy Bills Which Fix Medicaid Ge August 24, 2007 08:00:00The U.S. Chamber of Commerce has expressed strong support for the U.S. Senate and House of Representatives current efforts to address the problematic new pharmacy reimbursement formula for Medicaid generic prescription drugs. On Aug. 17, the Chamber sent Reps. Nancy Boyda (D-Kan.) and Jo Ann Emerson (R-Mo.), prime sponsors of H.R.3140, the "Saving Our Community Pharmacies Act of 2007", a letter endorsing their bill. The Chamber also sent a letter to Sen. Max Baucus (D-Mont. [click link for full article] - [Read more] |
| NICE Recommends Tysabri For Use In Highly Active Relapsing Remitting Multiple Sclerosis August 24, 2007 08:00:00Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) welcome final guidance announced by the National Institute for Health and Clinical Excellence (NICE) recommending use of TYSABRI (natalizumab) in people with highly active relapsing remitting multiple sclerosis (RRMS). TYSABRI is the first treatment for multiple sclerosis to be recommended for use by NICE. [click link for full article] - [Read more] |
| Eslax (Rocuronium Bromide) Approved In Japan August 24, 2007 08:00:00Organon, the human healthcare business unit of Akzo Nobel (Euronext Amsterdam: AKZ), announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved rocuronium bromide, its neuromuscular blocking agent (NMBA) for use during general anesthesia, under the brand name Eslax. [click link for full article] - [Read more] |
| FDA To Reconsider Plan To Close Seven Field Laboratories August 22, 2007 18:00:00FDA on Friday announced a decision to reconsider a plan to close seven of 13 field laboratories after lawmakers and advocacy groups raised concerns that the proposal would limit the ability of the agency to respond to public health emergencies, McClatchy/Seattle Times reports. [click link for full article] - [Read more] |
| Inhalation And Inhalers Gaining Ground In Drug Delivery August 22, 2007 08:00:00 At a time when the drug industry is striving for patient-friendly delivery methods for new and existing drugs, the growing availability of innovative inhaler device designs is driving interest in pulmonary drug delivery technology and devices as an alternative to oral and parenteral routes of administration. [click link for full article] - [Read more] |
| Alaska Allows Electronic Prescriptions August 21, 2007 15:00:00Alaska this week became the final state to allow physicians to send electronic drug prescriptions directly to pharmacists, the AP/Los Angeles Times reports. The move came after the state [click link for full article] - [Read more] |
| Funding To Help Patients Manage Their Medication, Australia August 21, 2007 09:00:00Older patients and people taking multiple medications are set to benefit from better packaging of their medicines by pharmacists.The Commonwealth Government has provided up to $72.9 million to the Pharmacy Guild of Australia through the Fourth Pharmacy Agreement for the Dose Administration Aids program. [click link for full article] - [Read more] |
| BIO Joins With Other Healthcare Organizations To Launch Disaster Response Initiative, USA August 21, 2007 09:00:00The Biotechnology Industry Organization (BIO) joined with other healthcare organizations involved in the manufacturing, distribution and dispensing of biologics and pharmaceutical products to create Rx Response - a program designed to support the continued delivery of medicines during a severe public health emergency. Rx Response was officially launched this week at events in New Orleans, LA and Miami, FL as those areas prepare for hurricane season. [click link for full article] - [Read more] |
| UCB Announces Submission Of Lacosamide Marketing Application For Diabetic Neuropathic Pain August 21, 2007 08:00:00UCB announced that an application for marketing authorization (MAA) for Vimpat® (lacosamide) as therapy for diabetic neuropathic pain has been submitted to the European Medicines Agency (EMEA) by UCBs subsidiary SCHWARZ PHARMA and has been accepted for review. "Treatment with Vimpat® significantly reduced pain in patients with diabetic neuropathic pain during the clinical trial program, which included more than 1,500 patients. [click link for full article] - [Read more] |
| European Biotech Industry Releases Policy On Biofuels In Europe August 21, 2007 08:00:00EuropaBio - the EU association for bioindustries - has released a consensus response to the "integrated energy and climate change package" proposal, endorsed by EU Heads of State earlier this year and currently discussed in European Parliament. The association sets out a policy for first and second generation biofuels. The available biomass in Europe will need to increase in order to achieve ambitious goals of biofuel use set by the European Union (5. [click link for full article] - [Read more] |
|
|